Skye Bioscience, Inc. Gain (Loss) on Extinguishment of Debt
Skye Bioscience, Inc. (SKYE) reported Gain (Loss) on Extinguishment of Debt of -$307.09 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-03-22
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$307.09K.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $117.95K.
- Skye Bioscience, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$307.09K 10-K · filed 2024-03-22 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $0.00 derived: sum of 2 quarters · filed 2024-03-22 | $0.00 derived: sum of 3 quarters · filed 2024-03-22 | $0.00 10-K · filed 2024-03-22 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $117.95K derived: sum of 3 quarters · filed 2023-03-31 | $117.95K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $117.95K derived: sum of 2 quarters · filed 2022-11-14 | $117.95K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $117.95K 10-Q · filed 2022-08-15 | $117.95K 10-Q · filed 2022-08-15 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $0.00 derived: sum of 3 quarters · filed 2022-03-28 | $0.00 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||
| 2019-12-31 | -$725.42K 10-K · filed 2021-03-02 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $0.00 derived: sum of 2 quarters · filed 2020-03-23 | $0.00 derived: sum of 3 quarters · filed 2020-03-23 | -$590.39K 10-K · filed 2020-03-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | -$590.39K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$590.39K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$590.39K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |